# FDA 483 - BEO Pharma Inc - November 04, 2024

Source: https://www.globalkeysolutions.net/records/483/beo-pharma-inc/4671e6d4-6bfe-4e75-81cf-3990222ffd4c

> FDA 483 for BEO Pharma Inc on November 04, 2024. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: BEO Pharma Inc
- Inspection Date: 2024-11-04
- Product Type: Drugs
- Office Name: Florida District Office

## Related Documents

- [483 - 2024-11-04](https://www.globalkeysolutions.net/records/483/beo-pharma-inc/7583132b-289f-4eed-9b1c-4f31b77861bb)
- [483 - 2024-11-04](https://www.globalkeysolutions.net/records/483/beo-pharma-inc/48de809c-ed40-458c-a612-ec39ca58b26a)
- [483 - Unknown Date](https://www.globalkeysolutions.net/records/483/beo-pharma-inc/c7448a8c-9d7c-4716-8793-4923df980505)
- [WARNING_LETTER - 2024-11-04](https://www.globalkeysolutions.net/records/warning_letter/beo-pharma-inc/408129b5-aeda-463b-a137-67a89d939d1a)
- [483 - 2024-11-04](https://www.globalkeysolutions.net/records/483/beo-pharma-inc/dacc5d15-d1c5-4408-b541-16bbc85b1e21)

## Related Officers

- [Pharmaceutical Investigator](https://www.globalkeysolutions.net/people/kayla-v-sprague/154cb543-111b-4ad1-b45b-43900df71b90)

Company: https://www.globalkeysolutions.net/companies/beo-pharma-inc/bc2943c1-de0c-4bf5-b29b-49563229a8fb

Office: https://www.globalkeysolutions.net/offices/florida-district-office/95b2a118-0b78-46e0-a54c-982bd7ce51c9